Evidence map›Paper›PMID 36171415›Full record

ReviewPlanta2022

Options for the generation of seedless cherry, the ultimate snacking product.

Edoardo Vignati, Marzena Lipska, Jim M Dunwell, Mario Caccamo, Andrew J Simkin

Abstract readReview
In one paragraph

Review in Planta, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Feeding the world: impacts of elevated [COHorticulture research · 2023
    Article
  5. Seedlessness Trait and Genome Editing-A Review.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Edoardo VignatiNIAB East Malling, Department of Genetics, Genomics and Breeding, New Road, West Malling, Kent, ME19 6BJ, UK.
Marzena LipskaNIAB East Malling, Department of Genetics, Genomics and Breeding, New Road, West Malling, Kent, ME19 6BJ, UK.
Jim M DunwellSchool of Agriculture, Policy and Development, University of Reading, Whiteknights, Reading, Berkshire, RG6 6EU, UK.ORCID http://orcid.org/0000-0003-2147-665X
Mario CaccamoNIAB, Cambridge Crop Research, Lawrence Weaver Road, Cambridge, CB3 0LE, UK.ORCID http://orcid.org/0000-0002-6244-3048
Andrew J SimkinNIAB East Malling, Department of Genetics, Genomics and Breeding, New Road, West Malling, Kent, ME19 6BJ, UK. a.simkin@kent.ac.uk.ORCID http://orcid.org/0000-0001-5056-1306

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MAIN

conclusionThis manuscript identifies cherry orthologues of genes implicated in the development of pericarpic fruit and pinpoints potential options and restrictions in the use of these targets for commercial exploitation of parthenocarpic cherry fruit. Cherry fruit contain a large stone and seed, making processing of the fruit laborious and consumption by the consumer challenging, inconvenient to eat 'on the move' and potentially dangerous for children. Availability of fruit lacking the stone and seed would be potentially transformative for the cherry industry, since such fruit would be easier to process and would increase consumer demand because of the potential reduction in costs. This review will explore the background of seedless fruit, in the context of the ambition to produce the first seedless cherry, carry out an in-depth analysis of the current literature around parthenocarpy in fruit, and discuss the available technology and potential for producing seedless cherry fruit as an 'ultimate snacking product' for the twenty-first century.

Indexed as

FruitSnacksSeedsCherryFruitJune dropParthenocarpySeed

Identifiers

PMID36171415
PMCPMC9519733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.